Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 
Inga Hofmann Zhang, MD close
cl3uUPr6II0
Inga Hofmann Zhang, MD
 

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Inga Hofmann Zhang, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Inga Hofmann was recently appointed Medical Director of our new PACT (Program for Advanced Cell Therapy) initiative, which is being led by Jacques Galipeau, MD, in the Department of Medicine. Dr. Hofmann's role with PACT will facilitate an important collaboration between Dr. Galipeau's new GMP lab and our Pediatric Bone Marrow Transplant Program. In fact, the very first product being developed by PACT will be cytomegalovirus (CMV) specific cytotoxic T cells for use in transplant patients experiencing CMV reactivation. This will be particularly beneficial as we expand our haploidentical transplant program, since these children are profoundly immunocompromised early post-transplant.

Specialties

Pediatric Hematology and Oncology

Acute Lymphoblastic Leukemia

Acute Myeloid Leukemia

Adrenocortical carcinoma

Aplastic Anemia

Astrocytoma

Ataxia-telengiectasia

Atypical Teratoid/Rhabdoid tumor

Bone Marrow Biopsy

Brain Stem Glioma

Chronic Myeloid Leukemia

Congenital Hemolytic Anemias

Craniopharyngioma

Cyclic Neutropenia

Diamond-Blackfan Syndrome

Endocrine Tumors

Ependymoma

Ewing Sarcoma

Fanconi's Anemia

Germ Cell Tumors

Hemophagocytic Lymphohistiocytosis

Hemophilia A

Hemophilia B

Hepatoblastoma

Hereditary Spherocytosis

Hodgkin's Disease

I-131 MIBG (Metaiodobenzylguadine)

Immune Thrombocytopenc Purpura

Immunotherapy

Juvenile Myelomonocytic Leukemia

Kostmann Syndrome

Langerhans' Cell Histiocytosis

Lumbar Puncture

Medulloblastoma

Myelodysplastic Syndromes

Neuroblastoma

Neurocutaneous Syndrome

Neurofibromatosis

Non-Hodgkin Lymphomas

Optic Glioma

Osteosarcoma

Paroxysmal Nocturnal Hemoglobinuria

Pediatric Bone Marrow Transplant

Pediatric Cancer

Pediatric Sickle Cell Disease

Retinoblastoma

Rhabdomyosarcoma

Schwanomatosis

Shwachman-Diamond Syndrome

Sturge-Weber Syndrome

Thalassemia Syndromes

Thrombophilia

Thyroid Tumors

Tuberous Sclerosis

Vascular malformations

Von Willebrand Disease

VonHippel-Lindau Disease

Wilms Tumor

Clinics

American Family Children's Hospital
(608) 263-6420 | (800) 323-8942 | Map
American Family Children's Hospital
(608) 263-6420 | (800) 323-8942 | Map

Hospital Affiliation(s)

American Family Children's Hospital

UW School of Medicine and Public Health

Department of Pediatrics

Professional Certifications and Education

Board Certification Pediatrics
Pediatric Hematology-Oncology
Fellowship

Pediatric Hematology/Oncology and Hematology/Oncology, Boston Children's Hospital, Boston, MA

Hematopathology, Brigham and Women's Hospital, Boston, MA

Pediatric Hematology/Oncology and Hematology/Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA

 


Residency University of California San Francisco Medical Center, San Francisco, CA
Internship University of California San Francisco Medical Center, San Francisco, CA
Medical School Albert Ludwigs University of Freiburg, Germany

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.
PubMed Articles
Xu R Tian X Zhang S An age-structured within-host HIV-1 infection model with virus-to-cell and cell-to-cell transmissions. J Biol Dyn . 2018 Dec;12(1):89-117
[PubMed ID: 29173134]
Shen S Chen W Dong L Yang Q Lu H Zhang J Design and synthesis of naphthalimide group-bearing thioglycosides as novel β-N-acetylhexosaminidases inhibitors. J Enzyme Inhib Med Chem . 2018 Dec;33(1):445-452
[PubMed ID: 29390898]
Wang B Liu T Wu Z Zhang L Sun J Wang X Synthesis and biological evaluation of stilbene derivatives coupled to NO donors as potential antidiabetic agents. J Enzyme Inhib Med Chem . 2018 Dec;33(1):416-423
[PubMed ID: 29374975]
Shen QK Chen ZA Zhang HJ Li JL Liu CF Gong GH Quan ZS Design and synthesis of novel oridonin analogues as potent anticancer agents. J Enzyme Inhib Med Chem . 2018 Dec;33(1):324-333
[PubMed ID: 29303372]
Zhang C Zhou Q Wu XN Huang YS Zhou J Lai Z Wu Y Luo HB Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer's disease. J Enzyme Inhib Med Chem . 2018 Dec;33(1):260-270
[PubMed ID: 29271265]
Li Q Zhang J Chen LZ Wang JQ Zhou HP Tang WJ Xue W Liu XH New pentadienone oxime ester derivatives: synthesis and anti-inflammatory activity. J Enzyme Inhib Med Chem . 2018 Dec;33(1):130-138
[PubMed ID: 29199491]
Hu J Pang WS Han J Zhang K Zhang JZ Chen LD Gualou Guizhi decoction reverses brain damage with cerebral ischemic stroke, multi-component directed multi-target to screen calcium-overload inhibitors using combination of molecular docking and protein-protein docking. J Enzyme Inhib Med Chem . 2018 Dec;33(1):115-125
[PubMed ID: 29185359]
Zhang C Gao Z Niu L Chen X Effects of triptolide on pharmacokinetics of amlodipine in rats by using LC-MS/MS. Pharm Biol . 2018 Dec;56(1):132-137
[PubMed ID: 29385884]
Sun S Wang R Fan J Zhang G Zhang H Effects of Danshen tablets on pharmacokinetics of atorvastatin calcium in rats and its potential mechanism. Pharm Biol . 2018 Dec;56(1):104-108
[PubMed ID: 29322864]
Soni KK Zhang LT Choi BR Karna KK You JH Shin YS Lee SW Kim CY Zhao C Chae HJ Kim HK Park JK Protective effect of MOTILIPERM in varicocele-induced oxidative injury in rat testis by activating phosphorylated inositol requiring kinase 1α (p-IRE1α) and phosphorylated c-Jun N-terminal kinase (p-JNK) pathways. Pharm Biol . 2018 Dec;56(1):94-103
[PubMed ID: 29316840]
Zhang Q Wang YL Gao D Cai L Yang YY Hu YJ Yang FQ Chen H Xia ZN Comparing coagulation activity of Selaginella tamariscina before and after stir-frying process and determining the possible active constituents based on compositional variation. Pharm Biol . 2018 Dec;56(1):67-75
[PubMed ID: 29295657]
Peng YG Zhang L Baohuoside-I suppresses cell proliferation and migration by up-regulating miR-144 in melanoma. Pharm Biol . 2018 Dec;56(1):43-50
[PubMed ID: 29260980]
Mei D Zhao L Chen B Zhang X Wang X Yu Z Ni X Zhang Q α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer. Drug Deliv . 2018 Nov;25(1):493-503
[PubMed ID: 29426250]
Zhang B Cheng G Zheng M Han J Wang B Li M Chen J Xiao T Zhang J Cai L Li S Fan X Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment. Drug Deliv . 2018 Nov;25(1):461-471
[PubMed ID: 29426237]
Yang L Song X Gong T Jiang K Hou Y Chen T Sun X Zhang Z Gong T Development a hyaluronic acid ion-pairing liposomal nanoparticle for enhancing anti-glioma efficacy by modulating glioma microenvironment. Drug Deliv . 2018 Nov;25(1):388-397
[PubMed ID: 29378465]
Gou Y Zhang Z Li D Zhao L Cai M Sun Z Li Y Zhang Y Khan H Sun H Wang T Liang H Yang F HSA-based multi-target combination therapy: regulating drugs' release from HSA and overcoming single drug resistance in a breast cancer model. Drug Deliv . 2018 Nov;25(1):321-329
[PubMed ID: 29350051]
Lin C Zhang X Chen H Bian Z Zhang G Riaz MK Tyagi D Lin G Zhang Y Wang J Lu A Yang Z Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide. Drug Deliv . 2018 Nov;25(1):256-266
[PubMed ID: 29334814]
Zhang T Yang R Yang S Guan J Zhang D Ma Y Liu H Research progress of self-assembled nanogel and hybrid hydrogel systems based on pullulan derivatives. Drug Deliv . 2018 Nov;25(1):278-292
[PubMed ID: 29334800]
Tao SC Rui BY Wang QY Zhou D Zhang Y Guo SC Extracellular vesicle-mimetic nanovesicles transport LncRNA-H19 as competing endogenous RNA for the treatment of diabetic wounds. Drug Deliv . 2018 Nov;25(1):241-255
[PubMed ID: 29334272]
Xie Z Liu G Tang P Sun X Chen S Qin A Zhu P Zhang J Fan S Bone-targeted methotrexate-alendronate conjugate inhibits osteoclastogenesis in vitro and prevents bone loss and inflammation of collagen-induced arthritis in vivo. Drug Deliv . 2018 Nov;25(1):187-197
[PubMed ID: 29303005]